Search

Your search keyword '"Maragna, R"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Maragna, R" Remove constraint Author: "Maragna, R"
112 results on '"Maragna, R"'

Search Results

2. Progression Of Atherosclerotic Plaque Determined By Computed Tomography Angiography: A Practical CCTA-based SCORE

3. Stress Computed Tomography Perfusion Versus Stress Cardiac Magnetic Resonance For The Management Of Suspected Or Known Coronary Arterydisease: Resources And Outcomes Impact (Strategy II Study)

4. Does the AVNeo valve reduce wall stress on the aortic wall? A cardiac magnetic resonance analysis with 4D-flow for the evaluation of aortic valve replacement with the Ozaki technique

5. Quantification of extracellular volume with cardiac computed tomography in patients with left ventricle dysfunction

6. Plasma exosomes reflect myocardial injury detected by cardiac magnetic resonance in STEMI patients

7. Stress computed tomography perfusion versus stress cardiac magnetic resonance for the management of suspected or known coronary artery disease: resources and outcomes impact (STRATEGY II Study)

8. Cardiac magnetic resonance for prophylactic implantable-cardioVerter defibrillator therapy international registry in patients with ischemic cardiomyopathy

9. Quantification Of Extracellular Volume With Cardiac Computed Tomography In Patients With Left Ventricle Dysfunction

11. Stress Computed Tomography Perfusion Versus Stress Cardiac Magnetic Resonance For The Management Of Suspectedor Known Coronary Artery Disease: Resources And Outcomes Impact (Strategy II Study)

12. Diagnostic Accuracy Of Dynamic Stress Myocardial Ct Perfusion As Compared With Invasive Coronary Physiology Assessment In Patients With Suspected In-stent Restenosis Or Cad Progression: Results Of Advantage 2 Study

14. Diagnostic performance of deep learning algorithm for analysis of computed tomography myocardial perfusion

15. P72 A CASE OF DRAMATIC HEART CHAMBERS REVERSE REMODELING AND DISEASE REGRESSION IN A PATIENT WITH HEART FAILURE AND END–STAGE RENAL FAILURE TREATED WITH SACUBITRIL/VALSARTAN AND SGLT2I: THE IMPORTANCE OF PUSHING THE BOUNDARIES

16. Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy

17. Is EuroSCORE II still a reliable predictor for cardiac surgery mortality in 2022? A retrospective study study

18. The Potential Role of Cardiac CT in the Evaluation of Patients With Known or Suspected Cardiomyopathy: From Traditional Indications to Novel Clinical Applications

20. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

21. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

22. Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study

23. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study

24. RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

25. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

26. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

27. Endomyocardial biopsy: what future in arrhythmogenic right ventricular dysplasia diagnosis?

29. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk

30. Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome

33. Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome

35. Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3

39. Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study

40. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

41. Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study

42. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

43. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

44. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

45. Diagnostic performance of deep learning algorithm for analysis of computed tomography myocardial perfusion

46. Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy

47. Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3

48. Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome

49. Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome

50. Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy.

Catalog

Books, media, physical & digital resources